コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ur of these genes (COL1A1, COL7A1, MMP7, and TLR6).
2 ial-derived agonists shared by TLR1, but not TLR6.
3 -like receptor (TLR) family members TLR2 and TLR6.
4 ce (TIR) deletion mutants of TLR1, TLR2, and TLR6.
5 hat this could be blocked by the presence of TLR6.
6 that human platelets express TLR2, TLR1, and TLR6.
7 EDN activates TLR2 independently of TLR1 or TLR6.
8 ting that the functional heterodimer is TLR2/TLR6.
9 TLR1, whereas the latter are favored by TLR2/TLR6.
10 pression of TLR4 or TLR2 with either TLR1 or TLR6.
11 econdary to deficient expression of TLR2 and TLR6.
12 s enhanced upon coexpression of TLR1 but not TLR6.
13 y TLR2 or co-expression of TLR2 with TLR1 or TLR6.
14 heir responses to ligands for TLR2, TLR1 and TLR6.
15 er component, bacterial lipopeptide, without TLR6.
16 inflammatory cytokines (IL-1a and IL-6), and TLR6.
17 ead region are three genes: TLR10, TLR1, and TLR6.
18 RI and TLR2 as well as its partners TLR1 and TLR6.
19 hich forms a heterodimer with either TLR1 or TLR6.
20 ation was enhanced by TLR1 and suppressed by TLR6.
21 CYSK4 (TLR1/2), flagellin (TLR5), and FSL-1 (TLR6/1) and have reduced responses to live Pseudomonas a
26 ed that signals generated following TLR2 and TLR6 activation were important for controlling viral rep
32 ated with asthma, as well as 4p14 near TLR1, TLR6 and TLR10 (rs2101521, P=5.3x10(-21)); 6p21.33 near
35 s) assayed in 4 TLR genes (TLR1, TLR2, TLR4, TLR6) and 2 adaptor molecules (TIRAP, MyD88) were associ
36 tivation of toll-like receptors (TLR1, TLR5, TLR6) and downstream markers (CCR1, MAPK14, ICAM1) leads
37 l variants in 4 TLR genes (TLR1, TLR2, TLR4, TLR6) and the adaptor molecule TIRAP between 205 African
38 ted by Toll-like receptors 2 and 6 (TLR2 and TLR6) and which induces hypoferremia in mice injected wi
39 lex composed of Toll-like receptor 4 (TLR4), TLR6, and CD36 induced by fibrillary Abeta peptides, the
40 n polymorphisms (indels) within bovine TLR2, TLR6, and PGLYRP1, thereby facilitating future TLR signa
41 TLR4 and the TLR2 heterodimers (with TLR1, TLR6, and possibly TLR10) require in addition the adapto
45 Immunogenetic analysis showed that TLR1, TLR6, and TLR10 single-nucleotide polymorphisms modulate
46 nd that human aortic ECs express TLR3, TLR4, TLR6, and TLR10, but only TLR4 was detected on the EC su
47 a broad range of TLRs, including TLR2, TLR3, TLR6, and TLR7/8, in addition to a previously identified
49 ining adaptor-inducing IFN-beta, TLR2, TLR4, TLR6, and TLR9 had no defect in their ability to respond
51 -like receptors (TLRs) TLR1, TLR2, TLR4, and TLR6 are evolutionarily conserved, highly homologous, an
52 ike receptors), we demonstrate that TLR2 and TLR6 are required for the activation of human and murine
53 affected the heterodimerization of TLR2 with TLR6 as well as the homodimerization of TLR4 as determin
58 veals that TLR10 is most related to TLR1 and TLR6, both of which mediate immune responses to a variet
59 o its heterodimerization with either TLR1 or TLR6, broadening its ligand diversity against pathogens.
60 ted response to this modulin was enhanced by TLR6 but inhibited by TLR1, indicating a functional inte
62 ombinations (chimeras with TLR1+TLR2 or TLR2+TLR6 but not TLR1+TLR6) resulted in LPS responsiveness,
64 acid replacements encoded by bovine TLR2 and TLR6, but not PGLYRP1, resulted in the confident predict
65 phagocytes via Toll-like receptor (TLR)2 and TLR6, but that GBS cell walls activate cells independent
66 from three to ten, including SNPs in or near TLR6, C11orf30, STAT6, SLC25A46, HLA-DQB1, IL1RL1, LPP,
68 ding to their extracellular domain, the TLR4-TLR6-CD36 complex assembly has been suggested to be indu
75 s expressing the chimeric TLR2/TLR1 and TLR2/TLR6 complexes, we report the selectivity of PorB bindin
79 ne marrow-derived macrophages from TLR1- and TLR6-deficient mice produced lower amounts of interleuki
81 lture and in BALB/c mice; the protection was TLR6 dependent and IL-12 dependent, and it was accompani
82 wo distinct, toll-like receptor (TLR) 2/TLR3/TLR6-dependent, hepatic inflammatory mouse settings.
83 on and show the potential of inhibiting TLR4-TLR6 dimerization as a treatment of Alzheimer's disease.
86 Our results support the idea that TLR1 and TLR6 diverged during evolution to differentially recogni
87 Unravelling the molecular basis of TLR1 and TLR6-driven heterodimerization upon LPA binding underlin
94 l that the transmembrane domains of TLR4 and TLR6 have an essential role in receptor dimerization and
95 -/-) mice with genetic deficiency of TLR2 or TLR6 have demonstrated that oxPCCD36 contribute to accel
96 novel diacylated lipopeptide ligand for TLR2-TLR6 heterodimer, induces IL-12-dependent, inducible NO
99 de insight into the mechanisms by which TLR2-TLR6 heterodimers recognize diacylated liporoteins, wher
100 gulated mRNA and protein expression of TLR1, TLR6, IL-25, and IL-33 in human atopic dermatitis skin l
102 nputs" such as cell surface receptors (e.g., TLR6, IL-7Ralpha) and functional "outputs" such as infla
103 nts in immune-related genes, including TLR3, TLR6, IL22RA2, IFNB1, and IFNA6, were identified in 19 p
104 on when TLR2 was co-transfected with TLR1 or TLR6 in 293T cells, but not when TLR1, 2, 3, 5, 6, or 9
108 e is functional interaction between TLR2 and TLR6 in the cellular response to STF and OspA-L in addit
109 er, our results demonstrate the role of TLR2/TLR6 in the host's inflammatory response to F. tularensi
111 es, the expression of TLR1 and TLR2, but not TLR6, increased; TLR2-TLR2 association increased, but TL
115 nd O. volvulus filaria are dependent on TLR2-TLR6 interactions and are mediated by adaptor molecules
116 LR2, together with its co-receptors CD14 and TLR6, is an innate sensor of DENV particles inducing inf
119 tion, peritoneal macrophages from wild-type, TLR6 knockout, and TLR1 knockout mice, but not TLR2 knoc
121 Our previous study showed the synthetic TLR2/TLR6 ligand fibroblast stimulating lipopeptide (FSL-1) p
122 CSK4 (a TLR1/TLR2 ligand), and Fsl-1 (a TLR2/TLR6 ligand) but not that by poly(I:C) (a TLR3 ligand) o
123 bisacycloxypropylcysteine (BPPcysMPEG; TLR2-TLR6 ligand) reduced L. major number in L. major-infecte
125 ound that DFE-induced activation of TLR1 and TLR6 may cause polarization toward a T helper type 2 imm
126 ed the mechanism or mechanisms through which TLR6 mediates this effect using mouse models of Aspergil
127 TLR2, in cooperation with either TLR1 or TLR6, mediates responses to a wide variety of microbial
134 ith immune response (TRAF1, RIPK3, BAT2, and TLR6), mitogen-activated protein kinase (MAPK) signaling
139 Toll-like receptor 1 (TLR1), TLR2, TLR4, TLR6, nucleotide-binding oligomerization domain receptor
140 omain of TLR2 can form functional pairs with TLR6 or TLR1, and this interaction leads to cytokine ind
142 in TLR1 (S248N and R80T), TLR2 (P631H), and TLR6 (P249S) were associated with an increased susceptib
143 during systemic infection, whereas the TLR2/TLR6 receptor complex induced IL-10(+) regulatory T cell
145 lthough TLR2 forms heterodimers with TLR1 or TLR6, recognizing different ligands, differences in the
148 y showing LPS pretreatment boosts subsequent TLR6 responses in mouse but not human macrophages, in ke
150 ras with TLR1+TLR2 or TLR2+TLR6 but not TLR1+TLR6) resulted in LPS responsiveness, indicating functio
151 of protein domain architectures for TLR2 and TLR6 revealed six regions of leucine-rich-repeat pattern
153 095, the CC genotype for TLR2 rs3804099, the TLR6 rs5743810 T allele, and the CC genotype for TIRAP r
154 secondary aims (PTX3, CLEC7a, CD209, CXCL10, TLR6, S100B, IFNG, PLG, TNFR1), with hazard ratios rangi
155 A) or TLR2-shRNA administration reduced, but TLR6-shRNA increased L. major infection in BALB/c mice.
156 out mice, we have demonstrated that TLR2 and TLR6 signaling in leukocytes can activate innate immunit
157 tein) is an adaptor in TLR1, TLR2, TLR4, and TLR6 signaling, whereas MyD88 is an adaptor for all TLRs
159 HT-29) were analyzed for expression of TLR2, TLR6, TLR1, and Toll inhibitory protein (Tollip) mRNA by
163 the highest Neandertal ancestry, we find the TLR6-TLR1-TLR10 cluster, which also contains functional
164 For example, Toll-like receptor 1 (TLR1)/TLR6/TLR10 gene cluster showed a strong signal of adapti
165 ied several immune pathways, among them TLR1/TLR6/TLR10, as being shaped by convergent evolution in t
167 Leukocytes express TLRs, including TLR2, TLR6, TLR3, TLR4, and TLR7, that can interact with RSV a
168 ) and Toll-like receptors (TLRs), only TLR2, TLR6, TLR7, and TLR9 contribute to the NF-kappaB-depende
169 proteolytic degradation is extended to TLR3, TLR6, TLR7, TLR8, TLR9, and TLR10, whereas the cellular
170 normal responses in mice lacking Tlr1, Tlr3, Tlr6, Tlr7, Tlr9, Tlr11 or the interleukin-18 receptor (
172 -helix ubiquitous kinase, IRAK1, TLR1, TLR4, TLR6, TLR8, TLR9, and TNFR-associated factor 6) were dow
175 b(R)LD, but not Sb(S)LD, interacts with TLR2/TLR6 to induce IL-10 by exploiting p50/c-Rel subunits of
176 TLR6 with the LRR derived from TLR1 enables TLR6 to recognize TUL4, FTT1103, and triacylated lipopep
178 that two members of the TLR family, TLR2 and TLR6, together coordinate macrophage activation by Gram-
180 on TLR2 expression, hetero-dimerization with TLR6, tyrosine phosphorylation, and recruitment of myelo
181 66; 95% confidence interval [CI] 0.52-0.85), TLR6 V427A (OR = 5.20; CI 1.77-15.3), SELPLG M264V (OR =
183 phenol-soluble modulin mediated by TLR2 and TLR6 was more refractory to inhibition by TLR1 than one
184 ivated macrophages independently of TLR2 and TLR6, whereas a response to the secreted GBS-F was not o
185 Substitution of the corresponding LRR of TLR6 with the LRR derived from TLR1 enables TLR6 to reco